NASDAQ : ATEC
Alphatec Holdings, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 11.37 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.76B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.09B |
| Enterprise Value | 1.61B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 155.14M |
| Shares Outstanding | 155.14M |
| Shares Change (YoY) | +4.64% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 10.27% |
| Owned by Institutions (%) | 75.17% |
| Float | 122.75M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 13.19 |
| PS Ratio | 1.30 |
| Forward PS | 1.14 |
| PB Ratio | 51.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 356.22 |
| P/OCF Ratio | 17.81 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.91 |
| EV / EBITDA | 30.35 |
| EV / EBIT | n/a |
| EV / FCF | 523.87 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.36 |
| Quick Ratio | 1.11 |
| Debt / Equity | 27.88 |
| Debt / EBITDA | 9.78 |
| Debt / FCF | 193.72 |
| Interest Coverage | -0.55 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -308.06% |
| Return on Assets (ROA) | -2.02% |
| Return on Invested Capital (ROIC) | -2.57% |
| Return on Capital Employed (ROCE) | -4.15% |
| Weighted Average Cost of Capital (WACC) | 8.02% |
| Revenue Per Employee | $919,738 |
| Profits Per Employee | -$95,166 |
| Employee Count | 913 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.29 |
Taxes
| Measure | Value |
|---|
| Income Tax | -1.81M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -57.31% |
| 50-Day Moving Average | 10.14 |
| 200-Day Moving Average | 10.56 |
| Relative Strength Index (RSI) | 27.16 |
| Average Volume (20 Days) | 4,036,053 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 13.28M |
| Short Previous Month | 14.07M |
| Short % of Shares Out | 8.56% |
| Short % of Float | 10.82% |
| Short Ratio (days to cover) | 6.04 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 839.72M |
| Gross Profit | 598.31M |
| Operating Income | -25.57M |
| Pretax Income | -88.69M |
| Net Income | -86.89M |
| EBITDA | 52.93M |
| EBIT | -25.57M |
| Loss Per Share | -$0.56 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 79.94M |
| Total Debt | 593.95M |
| Net Cash | -514.01M |
| Net Cash Per Share | -$3.31 |
| Equity (Book Value) | 21.30M |
| Book Value Per Share | -0.02 |
| Working Capital | 246.40M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 61.34M |
| Capital Expenditures | -58.28M |
| Depreciation & Amortization | 78.50M |
| Net Borrowing | -36.71M |
| Free Cash Flow | 3.07M |
| FCF Per Share | $0.02 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.25% |
| Operating Margin | -3.05% |
| Pretax Margin | -10.56% |
| Profit Margin | -10.35% |
| EBITDA Margin | 6.30% |
| EBIT Margin | -3.05% |
| FCF Margin | 0.37% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.64% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.96% |
| FCF Yield | 0.28% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $14.18 |
| Price Target Difference | 101.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 14.31% |
| EPS Growth Forecast (3Y) | 155.08% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 25, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.21 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |